veterinary Pain Management Market Size, Industry Analysis Report, Regional Outlook, Application Potential, Price Trends, Competitive Market Share & Forecast, 2021 – 2027
Report ID: GMI4198
Veterinary Pain Management Market size is projected to experience significant growth from 2019 to 2025.
Growing pet adoption across developed and developing regions will augment the global veterinary pain management market growth in the forthcoming years. Over 6 million abandoned cats and dogs are adopted in the U.S. every year. With increasing pet adoption, the demand for animal care products and adoption of sophisticated treatment for pet diseases is growing across the developed nations, thereby increasing the veterinary pain management market growth. In addition, rising disposable income and spending on animal care will offer robust growth for the veterinary pain management business in the upcoming years.
Increasing incidence of animal diseases will boost the demand for animal pain management drugs and devices. Pet diseases such as diabetes, dental diseases, otitis externa and cancer among several others are commonly diagnosed. Periodontal diseases such as gingivitis and periodontitis are the most common diseases in cats and dogs and involve pain. Therefore, proper monitoring of animal diseases and treatment including pain management is necessary. Thus, with growing pet adoption and various pet disease incidence, the demand for veterinary pain management therapeutics will increase over the future years.
However, high costs associated with few pet care drugs and devices may restrain the market growth in the coming years.
Veterinary pain management drugs will hold significant revenue size during the forecast years owing to high prevalence of chronic diseases in animals. Increasing demand for drugs in management of acute pain conditions for instant relief will positively impact the segmental growth. Moreover, product approvals of novel therapies for treatment of pain in animals will expand the segmental growth over the foreseeable years.
Joint pain segment is estimated to grow at a robust rate during the forecast years owing to high prevalence of osteoarthritis in canine animals. According to the U.S. Food and Drug Administration, osteoarthritis is commonly diagnosed disease in dogs and older cats affecting about 74 of 218 cats. Introduction of novel therapies for joint pain management will boost the market growth. For instance, in April 2019, Boehringer Ingelheim launched Arti-Cell Forte, first stem cell-based product for reduction of lameness associated with joint inflammation. Additionally, limited treatment options will pose lucrative opportunity for the players to introduce novel therapies, thereby augmenting the segmental growth.
Companion animal segment is forecast to grow at a significant pace owing to high adoption rate of companion animals. According to the American Society for the Prevention of Cruelty to Animals, approximately 6.5 million companion animals enter animal shelter every year. Moreover, increasing incidence of chronic disease in companion animals such as cancer and osteoarthritis will further impel the demand for pain management drugs and devices for companion animals.
Clinics segment will hold considerable market size over the forthcoming years owing to availability of wide range of treatment as well as diagnostic aids in veterinary clinics. Clinics are convenient alternatives for quick access and therapy. Moreover, increasing number of surgeries in clinics will upsurge the demand of veterinary medicines, thereby boosting the market growth.
U.S. veterinary pain management market will hold a significant share over the projected timeframe owing to high adoption of pets coupled with increasing awareness regarding maintaining animal health. According to American Society for the Prevention of Cruelty to Animals, approximately 44% American house-holds owned dogs and 35% owned cats during 2015 to 2016. Increasing pet health insurance and rising veterinary expenses will further positively influence the U.S. veterinary pain management industry growth. For instance, according to North America Pet Health Insurance Association, 2.16 million pets were insured in the U.S. in 2018, thereby augmenting the market growth.
India veterinary pain management market is projected to grow at a momentous pace in the coming years due to large livestock population in the region. Growing pet adoption and increasing expenditure on pet health improvement will further assist the market growth. Moreover, rise in initiatives by the Indian government to promote pet health will highly contribute to the market growth. For instance, the Animal Welfare Board of India (AWBI) provides financial assistance for construction and maintenance of animal shelters and purchase of veterinary medicines and equipment. Such initiatives will offer lucrative market growth opportunities over the foreseeable future.
Some of the major market players involved in the global veterinary pain management market are Assisi Animal Health, Bayer, Boehringer Ingelheim, and Ceva Santé Animale among others. Firms are implementing business strategies such as mergers and acquisitions, partnerships and product launch to broaden their product portfolio and increase the revenue share. For instance, in April 2019, Elanco signed an agreement to acquire Aratana Therapeutics to broaden the veterinary therapeutics business.
Veterinary Pain Management Market by Product Category, 2014-2025 (USD Million)
- Drugs, By Type
- Local Anesthetics
- Alpha-2 Agonists
- Drugs, By Route of Administration
- Drugs, By Type
- Laser Therapy
- Electromagnetic Therapy
Veterinary Pain Management Market by Application, 2014-2025 (USD Million)
- Joint Pain
- Post-operative pain
Veterinary Pain Management Market by Animal Type, 2014-2025 (USD Million)
- Companion Animals
Veterinary Pain Management Market by Distribution Channel, 2014-2025 (USD Million)
The above information is provided for the following regions and countries:
- North America
- Asia Pacific
- Latin America
- Middle East and Africa
- South Africa
- Saudi Arabia
- Assisi Animal Health
- Boehringer Ingelheim
- Ceva Santé Animale
- Dechra Pharmaceuticals
- K-Laser USA
- Merck Animal Health
- Norbrook Laboratories
What Information does this report contain?
Customize this Report
Our Market Research Reports Include:
- Market snapshot
- Market Segmentation
- Value Chain Analysis
- Growth Dynamics
- Potential Market Opportunities
- Regulatory Overview
- Technology Evolution
- Innovation & Sustainability
Benefits of Association
Data Coverage & Quality
GMI reports provide the most comprehensive coverage of any focus industry, ensuring a holistic and deep understanding of the market, along with actionable and granular data. We also take pride in our commitment to quality and strive to ensure that our clients get their moneys worth.
Client Trust & Security
GMI maintains strict code of conduct as a business and is committed to ensure that the privacy and trust of our clients are always maintained. As an organization, we also strive to be fully compliant with privacy laws, PCI and information security guidelines.
Our customers rely on us to produce accurate, reliable and timely information. Service orientation is a key mission for us as an organization; our process is guided by the desire to ensure that our clients are provided the best possible solutions in optimal timeframe. GMI stands by its commitment to service, providing timely assistance in both pre-sales and post-sales support for our clients.